Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging

被引:218
作者
Ng, Arnold C. T. [1 ,2 ,3 ]
Delgado, Victoria [4 ]
Borlaug, Barry A. [5 ]
Bax, Jeroen J. [4 ]
机构
[1] Princess Alexandra Hosp, Dept Cardiol, Brisbane, Qld, Australia
[2] Translat Res Inst, Brisbane, Qld, Australia
[3] Univ New South Wales, Sydney, NSW, Australia
[4] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands
[5] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA
基金
美国国家卫生研究院;
关键词
EPICARDIAL ADIPOSE-TISSUE; PRESERVED EJECTION FRACTION; INDUCED WEIGHT-LOSS; BODY-MASS INDEX; CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE; MAGNETIC-RESONANCE-SPECTROSCOPY; MYOCARDIAL SUBSTRATE METABOLISM; CORONARY-ARTERY-DISEASE; GASTRIC BYPASS-SURGERY; NECROSIS-FACTOR-ALPHA;
D O I
10.1038/s41569-020-00465-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this Review, Bax and colleagues summarize the effects of obesity and diabetes on myocardial structure and function and evaluate the role of multimodality cardiac imaging to elucidate the pathophysiology of myocardial dysfunction, prognosticate long-term clinical outcomes and potentially guide treatment strategies. Diabesity is a term used to describe the combined adverse health effects of obesity and diabetes mellitus. The worldwide dual epidemic of obesity and type 2 diabetes is an important public health issue. Projections estimate a sixfold increase in the number of adults with obesity in 40 years and an increase in the number of individuals with diabetes to 642 million by 2040. Increased adiposity is the strongest risk factor for developing diabetes. Early detection of the effects of diabesity on the cardiovascular system would enable the optimal implementation of effective therapies that prevent atherosclerosis progression, cardiac remodelling, and the resulting ischaemic heart disease and heart failure. Beyond conventional imaging techniques, such as echocardiography, CT and cardiac magnetic resonance, novel post-processing tools and techniques provide information on the biological processes that underlie metabolic heart disease. In this Review, we summarize the effects of obesity and diabetes on myocardial structure and function and illustrate the use of state-of-the-art multimodality cardiac imaging to elucidate the pathophysiology of myocardial dysfunction, prognosticate long-term clinical outcomes and potentially guide treatment strategies.
引用
收藏
页码:291 / 304
页数:14
相关论文
共 192 条
[51]   Cardiac neuroanatomy - Imaging nerves to define functional control [J].
Hanna, Peter ;
Rajendran, Pradeep S. ;
Ajijola, Olujimi A. ;
Vaseghi, Marmar ;
Armour, J. Andrew ;
Ardell, Jefrrey L. ;
Shivkumar, Kalyanam .
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2017, 207 :48-58
[52]   Reversibility of myocardial metabolism and remodelling in morbidly obese patients 6 months after bariatric surgery [J].
Hannukainen, Jarna C. ;
Lautamaki, Riikka ;
Parkka, Jussi ;
Strandberg, Marjatta ;
Saunavaara, Virva ;
Hurme, Saija ;
Soinio, Minna ;
Dadson, Prince ;
Virtanen, Kirsi A. ;
Gronroos, Tove ;
Forsback, Sarita ;
Salminen, Paulina ;
Iozzo, Patricia ;
Nuutila, Pirjo .
DIABETES OBESITY & METABOLISM, 2018, 20 (04) :963-973
[53]   Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats [J].
Hasselbaink, DM ;
Glatz, JFC ;
Luiken, JJFP ;
Roemen, THM ;
Van der Vusse, GJ .
BIOCHEMICAL JOURNAL, 2003, 371 (03) :753-760
[54]  
Hattori N, 1996, J NUCL MED, V37, P1985
[55]   Left Ventricular Mass and Function With Reduced-Fat or Reduced-Carbohydrate Hypocaloric Diets in Overweight and Obese Subjects [J].
Haufe, Sven ;
Utz, Wolfgang ;
Engeli, Stefan ;
Kast, Petra ;
Boehnke, Jana ;
Pofahl, Martin ;
Traber, Julius ;
Haas, Verena ;
Hermsdorf, Mario ;
Maehler, Anja ;
Busjahn, Andreas ;
Wiesner, Susanne ;
Otto, Christoph ;
Mehling, Heidrun ;
Luft, Friedrich C. ;
Boschmann, Michael ;
Schulz-Menger, Jeanette ;
Jordan, Jens .
HYPERTENSION, 2012, 59 (01) :70-U174
[56]   Joint estimation of water/fat images and field inhomogeneity map [J].
Hernando, D. ;
Haldar, J. P. ;
Sutton, B. P. ;
Ma, J. ;
Kellman, P. ;
Liang, Z. -P. .
MAGNETIC RESONANCE IN MEDICINE, 2008, 59 (03) :571-580
[57]   Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-α-induced cardiomyopathy [J].
Higuchi, Y ;
McTiernan, CF ;
Frye, CB ;
McGowan, BS ;
Chan, TO ;
Feldman, AM .
CIRCULATION, 2004, 109 (15) :1892-1897
[58]   Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus [J].
Holland, David J. ;
Marwick, Thomas H. ;
Haluska, Brian A. ;
Leano, Rodel ;
Hordern, Matthew D. ;
Hare, James L. ;
Fang, Zhi You ;
Prins, Johannes B. ;
Stanton, Tony .
HEART, 2015, 101 (13) :1061-1066
[59]   Role of orlistat in the treatment of obese patients with type 2 diabetes - A 1-year randomized double-blind study [J].
Hollander, PA ;
Elbein, SC ;
Hirsch, IB ;
Kelley, D ;
McGill, J ;
Taylor, T ;
Weiss, SR ;
Crockett, SE ;
Kaplan, RA ;
Comstock, J ;
Lucas, CP ;
Lodewick, PA ;
Canovatchel, W ;
Chung, J ;
Hauptman, J .
DIABETES CARE, 1998, 21 (08) :1288-1294
[60]   Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes [J].
Hollander, Priscilla ;
Gupta, Alok K. ;
Plodkowski, Raymond ;
Greenway, Frank ;
Bays, Harold ;
Burns, Colleen ;
Klassen, Preston ;
Fujioka, Ken .
DIABETES CARE, 2013, 36 (12) :4022-4029